A practical blueprint for companies and CEOs that shows how to secure agentic systems by shifting from prompt tinkering to hard controls on identity, tools, and data.

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...

(MENAFN- EIN Presswire) EINPresswire/ -- The Genomic Risk Stratification Test Market is projected to experience substantial growth over the next decade as healthcare providers and diagnostic ...

A global data center developer is linked to large land purchases in Caddo and Bossier parishes. Public records connect STACK Infrastructure to the acquisitions through an LLC sharing its corporate ...

Adaptive test is starting to gain traction for high-performance computing and AI chips as test programs that rely on static limits and fixed test sequences reach their practical limits. The growing ...

California-based Artera, a company that develops multimodal AI-based prognostic and predictive cancer tests, has been granted de novo authorization by the FDA for its AI tool for prostate cancer ...

FRIENDSWOOD, Texas, July 23, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences (CSTL), Inc. , a company improving health through innovative tests that guide patient care, today announced that its DecisionDx ...

Quest Diagnostics will work on a blood test for cancer risk it says may help identify people who could benefit from more frequent screenings using technology developed at the MD Anderson Cancer Center ...

(RTTNews) - Quest Diagnostics Incorporated (DGX), a provider of diagnostic information services, Tuesday said it partnered with The University of Texas MD Anderson Cancer Center to develop a ...

SECAUCUS, N.J., June 10, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a collaboration with The University of Texas MD ...